News Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD MonitoringHealthradar24. Juli 2026 What You Should Know Tempus AI, Inc. has entered into a definitive agreement to acquire Personalis, Inc. for $16.25 per…
News Tempus to buy cancer test-maker Personalis for $1.5BHealthradar20. Juli 2026 Dive Brief: Tempus AI said Monday it has agreed to buy Personalis for $1.5 billion. Fremont, California-based Personalis makes a…
News Personalis Expands Tempus AI Collaboration to Include Colorectal CancerHealthradar10. Juli 2025 What You Should Know: – Personalis, Inc. announced a significant expansion and extension of its strategic collaboration with Tempus AI,…
